Published in J Clin Oncol on February 07, 2011
Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study. Cancer (2015) 1.80
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34
Clinical signs of impending death in cancer patients. Oncologist (2014) 1.10
Association between bone scan index and activities of daily living in patients with advanced non-small cell lung cancer. Support Care Cancer (2017) 1.08
Treating nausea and vomiting in palliative care: a review. Clin Interv Aging (2011) 1.04
Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer (2012) 0.99
Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer (2012) 0.99
The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea. J Palliat Med (2013) 0.92
Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System. J Pain Symptom Manage (2015) 0.91
Prognostication of Survival in Patients With Advanced Cancer: Predicting the Unpredictable? Cancer Control (2015) 0.89
Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial. BMC Pulm Med (2012) 0.85
Symptom Expression in the Last Seven Days of Life Among Cancer Patients Admitted to Acute Palliative Care Units. J Pain Symptom Manage (2014) 0.84
Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. Support Care Cancer (2013) 0.83
Comparison of timing and decision-makers of do-not-resuscitate orders between thoracic cancer and non-cancer respiratory disease patients dying in a Japanese acute care hospital. Support Care Cancer (2014) 0.83
End-of-life hospital referrals by out-of-hours general practitioners: a retrospective chart study. BMC Fam Pract (2012) 0.82
Sequential occurrence of dyspnea at the end of life in palliative care, according to the underlying cancer. Cancer Med (2015) 0.80
The Edmonton Symptom Assessment System 25 Years Later: Past, Present and Future Developments. J Pain Symptom Manage (2016) 0.78
A Prospective Evaluation of Symptom Prevalence and Overall Symptom Burden Among Cohort of Critically Ill Cancer Patients. Indian J Palliat Care (2016) 0.78
Unexpected death in palliative care: what to expect when you are not expecting. Curr Opin Support Palliat Care (2015) 0.78
Personalized symptom goals and response in patients with advanced cancer. Cancer (2016) 0.77
Emergency visits among end-of-life cancer patients in Taiwan: a nationwide population-based study. BMC Palliat Care (2015) 0.77
Prevalence of severe depressive symptoms increases as death approaches and is associated with disease burden, tangible social support, and high self-perceived burden to others. Support Care Cancer (2015) 0.77
Does a regional comprehensive palliative care program improve pain in outpatient cancer patients? Support Care Cancer (2014) 0.76
How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature. Support Care Cancer (2016) 0.76
A diagnostic model for impending death in cancer patients: Preliminary report. Cancer (2015) 0.76
Editorial - Reflection on End-of-Life Care. Ochsner J (2011) 0.76
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer (2014) 0.76
Defining Health Across the Cancer Continuum. Cureus (2017) 0.75
Palliative oncology: identity, progress, and the path ahead. Ann Oncol (2012) 0.75
Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? BMJ Open (2015) 0.75
Edmonton Symptom Assessment System screening and depression at the end of life. J Clin Oncol (2011) 0.75
Symptom scores and delirium in advanced cancer. J Clin Oncol (2011) 0.75
Symptom Burden and Functional Gains in a Cancer Rehabilitation Unit. Int J Ther Rehabil (2015) 0.75
Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity. J Pain Symptom Manage (2015) 0.75
The last days of life: symptom burden and impact on nutrition and hydration in cancer patients. Curr Opin Support Palliat Care (2015) 0.75
Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice. Curr Oncol (2015) 0.75
Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer. Support Care Cancer (2016) 0.75
Symptom profiles in children with advanced cancer: Patient, family caregiver, and oncologist ratings. Cancer (2015) 0.75
Variations in the cost of formal and informal health care for patients with advanced chronic disease and refractory breathlessness: A cross-sectional secondary analysis. Palliat Med (2017) 0.75
Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan. Support Care Cancer (2016) 0.75
Impact of dyspnea on advanced cancer patients referred to a palliative radiotherapy clinic. Support Care Cancer (2017) 0.75
Emergency department visits after hours by lung cancer patients in Japan. Support Care Cancer (2013) 0.75
Which quality of life instruments are preferred by cancer patients in Japan? Comparison of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Functional Assessment of Cancer Therapy-General. Support Care Cancer (2014) 0.75
Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study. Support Care Cancer (2016) 0.75
Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study. Support Care Cancer (2016) 0.75
Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study. Support Care Cancer (2016) 0.75
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Genome-wide atlas of gene expression in the adult mouse brain. Nature (2006) 28.02
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell (2011) 11.44
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
FaST linear mixed models for genome-wide association studies. Nat Methods (2011) 6.52
The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet (2005) 6.22
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol (2010) 6.01
Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol (2011) 5.67
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol (2003) 4.73
Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol (2009) 4.07
Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology (2010) 3.91
Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89
Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work. N Engl J Med (2015) 3.88
Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell (2011) 3.78
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology (2008) 3.71
Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol (2009) 3.36
Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11
Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta (2006) 3.10
Are family medicine residents adequately trained to deliver palliative care? Can Fam Physician (2015) 2.90
Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89
An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity (2011) 2.77
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 2.70
Structure and function of a transcriptional network activated by the MAPK Hog1. Nat Genet (2008) 2.67
Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A (2011) 2.66
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med (2010) 2.58
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol (2013) 2.53
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med (2005) 2.46
Anatomical traits associated with absorption and mycorrhizal colonization are linked to root branch order in twenty-three Chinese temperate tree species. New Phytol (2008) 2.43
A population-based analysis of outpatient colonoscopy in adults assisted by an anesthesiologist. Anesthesiology (2009) 2.41
Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci (2012) 2.35
Proliferation of prenatal ultrasonography. CMAJ (2010) 2.33
Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol (2013) 2.32
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol (2011) 2.31
IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation (2011) 2.29
Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci (2004) 2.27
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg (2013) 2.19
Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genet (2012) 2.19
Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. J Clin Oncol (2011) 2.18
A document clustering and ranking system for exploring MEDLINE citations. J Am Med Inform Assoc (2007) 2.18
Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol (2010) 2.16
End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst (2011) 2.14
Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol (2003) 2.08
Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels. Kidney Int (2013) 2.05
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst (2006) 2.01
Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small (2011) 2.00
Why do patients with cancer visit the emergency department near the end of life? CMAJ (2010) 1.95
When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology. J Natl Cancer Inst (2010) 1.95
Bis(acetato-κO)[1,2-bis-(2-pyridylmeth-oxy)benzene-κN,O,O',N']copper(II) monohydrate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.94
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One (2011) 1.93
The importance of reporting patient recruitment details in phase III trials. J Clin Oncol (2006) 1.92
The chemistrode: a droplet-based microfluidic device for stimulation and recording with high temporal, spatial, and chemical resolution. Proc Natl Acad Sci U S A (2008) 1.90
A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. J Hum Genet (2010) 1.89
Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell (2013) 1.89
Comparison of adenoviruses from species B, C, E, and F after intravenous delivery. Mol Ther (2007) 1.88
Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men. J Urol (2010) 1.87
Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci U S A (2010) 1.85
Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways. J Neurosci (2005) 1.81
Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci (2002) 1.80
An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg (2002) 1.80
Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology (2006) 1.76
Addiction related alteration in resting-state brain connectivity. Neuroimage (2009) 1.76
Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev (2004) 1.75
A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol (2011) 1.73
A cryptographic approach to securely share and query genomic sequences. IEEE Trans Inf Technol Biomed (2008) 1.71
Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. Anal Chem (2008) 1.69
Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks. Int J Radiat Oncol Biol Phys (2005) 1.69
Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc (2012) 1.67
Exercise and the metabolic syndrome with weight regain. J Appl Physiol (1985) (2010) 1.66
Structural basis for the modular recognition of single-stranded RNA by PPR proteins. Nature (2013) 1.66
Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer. J Urol (2012) 1.66
A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol (2006) 1.65
Preferences for place of care and place of death among informal caregivers of the terminally ill. Palliat Med (2005) 1.63
Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells (2007) 1.62
Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol (2003) 1.62
The lexical constituency model: some implications of research on Chinese for general theories of reading. Psychol Rev (2005) 1.61
catena-Poly[[bis-(nitrato-κO)copper(II)]-bis-[μ-1,4-bis-(pyridin-3-ylmeth-oxy)benzene-κN:N']]. Acta Crystallogr Sect E Struct Rep Online (2011) 1.61
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg (2014) 1.61
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol (2010) 1.60
Noninvasive evaluation of coronary distensibility in older adults: a feasibility study with MR angiography. Radiology (2011) 1.60
A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells (2009) 1.59
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression. PLoS Biol (2010) 1.58
Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet (2010) 1.57
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc Natl Acad Sci U S A (2013) 1.57
The coexistence of superconductivity and topological order in the Bi₂Se₃ thin films. Science (2012) 1.56
Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology (2008) 1.56
Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause (2010) 1.56
Semantic Similarity and Relatedness between Clinical Terms: An Experimental Study. AMIA Annu Symp Proc (2010) 1.56
Efficacy of contrast-enhanced US and magnetic microbubbles targeted to vascular cell adhesion molecule-1 for molecular imaging of atherosclerosis. Radiology (2011) 1.55
Structure of C3PO and mechanism of human RISC activation. Nat Struct Mol Biol (2011) 1.55
Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem (2003) 1.54
Mutations in the AXIN1 gene in advanced prostate cancer. Eur Urol (2008) 1.53
Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications. Discov Med (2011) 1.52
Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int (2014) 1.51
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One (2011) 1.50
Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev (2007) 1.50
Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet (2011) 1.49